Another study has shown that compared with the normal elderly group, miR-34a in blood mononuclear cells of AD patients is significantly down-regulated for regulating the phosphorylation of Tau (39), suggesting that miR-34a could be used as a non-invasive biomarker for AD. Here, MAPT is linked to Alzheimer disease.